Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Off-The-Shelf CAR T-Cell Therapy with John McKearn, Ph.D.

    Off-The-Shelf CAR T-Cell Therapy with John McKearn, Ph.D.

    FromBusiness Of Biotech

    Start listeningView podcast show

    Off-The-Shelf CAR T-Cell Therapy with John McKearn, Ph.D.

    FromBusiness Of Biotech

    ratings:
    Length:
    39 minutes
    Released:
    Oct 26, 2020
    Format:
    Podcast episode

    Description

    Find out what drove John McKearn, Ph.D. & CEO at Wugen, out of the lab at Pfizer and on to his quest to develop off-the-shelf cell therapies for T-Cell leukemias and lymphomas, Acute Myeloid Leukemia, and Multiple Myeloma.
    Released:
    Oct 26, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.